Assessment of Rural Health Care: Implementing TRAK Digital Tool for Quality and Accessible Services
NCT ID: NCT06796309
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
95 participants
INTERVENTIONAL
2024-02-07
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will undergo telerehabilitation treatment through the TRAK platform for eight weeks (treatment group) or follow an at home exercise protocol (control group).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Affective Based Integrated Care for Better Quality of Life.Pilot Implementation. Site1: Primary Care Madrid, Spain.
NCT05681065
Evaluate the Effectiveness of a Virtual Community of Practice
NCT06046326
Technologies for Participatory Medicine and Health Promotion in the Elderly Population
NCT03504813
Study on Cardiovascular Health, Nutrition and Physical Functioning in Older Adults in Spain
NCT03541135
Enhanced Primary Care for Elderly
NCT03180606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the initial screening, individuals who meet the study's predefined inclusion criteria will be invited to participate. Before enrollment, written informed consent will be obtained from all participants, ensuring ethical compliance and respect for individual autonomy.
The healthcare personnel (population 1) will use Trak during the entire study period, from the time of entry into the study to the time of exit.
The study cohort will consist of patients randomly assigned to the experimental group (EG) and the control group (CG) on the first in person visit for the population 2 (patients). Regardless of group assignment, all patients will undergo baseline health assessments, ensuring that their individual needs are met. The satisfaction questionnaire will be deferred until post-intervention for both groups.
Participants in both groups will begin by filling out the Quality of Life Scale (EuroQol 5). and Shoulder Functional Assessment Scale (SPADI-Br) on the first visit.
In the case of the treatment group (EG), the participants will use the platform following the treatment prescribed by their health professionals for a period of 2 months. in the case of the control group (CG), the patients will follow the usual clinical practice treatment (they will receive the exercise protocol in paper format).
At the end of the treatment period, a final face-to-face visit will be made.
Patients (population 2) will undergo 8 weeks of treatment through the TRAK tool (https://www.trakphysio.com/es/) in the EG. Patients from the EG will carry out the treatment through the platform at home, and those from the CG will follow an on paper exercise protocol based on the usual (in-person) clinical practice methodology. Both groups will perform exercises in these rehabilitation sessions to improve shoulder mobility.
The results will be evaluated using different métrics, such as Telemedicine Usability Questionnaire (TUQ) and Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ), wich are the main ones, number of patients using the platform, the EuroQol-5D and the shoulder functional evaluation scale (SPADI-Br). These scales will be completed on paper at the beginning and end of the study for both groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Population 1:
Fifteen healthcare professionals will be recruited.
The intervention targets patients with musculoskeletal pathologies using randomized allocation into two groups: a treatment group utilizing Trak and a control group following conventional rehabilitation methods.
Population 2:
Eighty patients will be randomly assigned to the experimental or control group in a 1:1 ratio.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRAK treatment group (Population 2)
Patients will use Trak platform for 8 weeks (2 months) for their exercise program. The use of the tool involves performing the corresponding therapeutic exercise program through it. The frequency of the exercises will be determined by the healthcare professional responsible for the patient, based on the needs identified during the assessment, ranging from 3 to 7 days per week.
Trak Telerehabilitation Platform
The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.
Control Group (Population 2)
Patients in the control group will undergo the same rehabilitation period (8 weeks) but following standard clinical practice.
Conventional Rehabilitation Program
Exercise protocol with the methodology of conventional clinical practice.
Healthcare professional Group (Population 1)
Healthcare professionals who will have access to the tool to prescribe exercise sessions for their patients, monitor their progress, adapt and modify the exercise program, communicate with patients to address their questions, and track their progress over time.
Trak Telerehabilitation Platform
The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trak Telerehabilitation Platform
The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.
Conventional Rehabilitation Program
Exercise protocol with the methodology of conventional clinical practice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* That they know how to use the tool.
* That they have a device with which to use the tool.
* That they have an e-mail address.
* That they have an Internet connection.
* That they have signed the informed consent form.
* Seniors.
* Patients with omalgia of more than 6 months of evolution.
* Who have a device with which to use the tool.
* Who have a device with which to use the tool.
* Who have an Internet connection.
* Who have an e-mail address.
* Who have signed the informed consent form.
Exclusion Criteria
* Patients with cognitive impairment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Gregorio Marañón
OTHER
Trak Health Solutions S.L.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ANA VADILLO CORTÁZAR
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario del Sureste
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario del Sureste
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRAK-RURAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.